National Institute of Science and Technology of Drugs and Medicines
- Research works
- 23 ▼ 29% vs 2013–17
- Citations
- 565 24.3 per fractional work
- Top-10% rate
- 36.9% record average 16.5%
- Open access
- 64% world 28%
Not ranked overall: National Institute of Science and Technology of Drugs and Medicines is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.3×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 8.3×
- Biochemistry, Genetics and Molecular Biology 8.0×
- Chemistry 4.6×
- Immunology and Microbiology 3.3×
- Decision Sciences 2.2×
- Health Professions 1.6×
- Medicine 1.2×
- Social Sciences 0.8×
- Agricultural and Biological Sciences 0.4×
- Computer Science 0.3×
- Economics, Econometrics and Finance 0.2×
Which keywords describe research at National Institute of Science and Technology of Drugs and Medicines?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Treatment, Diagnosis, Vaccine, Immune Response, Cancer, Antioxidant and Drug Resistance.
- Pharmacology
- Health Biotechnology
- Medicinal Plants
- Drug Resistance
- Antioxidant
- Vaccine
- Cancer
- Treatment
- Epidemiology
- Diagnosis
- Immune Response
- Inflammation
- Anti-inflammatory
- Education
- Global Collaboration
- Innovation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- Epidemiology4▲ 4.9×24 topics
- Treatment2▲ 7.6×9 topics
- Diagnosis2▲ 8.4×7 topics
- Cancer2▲ 5.6×9 topics
- Immune Response2▲ 13×8 topics
- Vaccine2▲ 20×7 topics
- Inflammation2▲ 2.9×9 topics
- Antioxidant2▲ 9.2×8 topics
- Anti-inflammatory1▲ 20×9 topics
- Drug Resistance1▲ 18×5 topics
- Education1▲ 3.6×3 topics
- Medicinal Plants1▲ 12×6 topics
- Global Collaboration1▲ 105×1 topic
- Health Biotechnology1▲ 226×1 topic
- Innovation1▲ 4.9×2 topics
- Pharmacology1▲ 13×5 topics
Which research topics does National Institute of Science and Technology of Drugs and Medicines publish most on?
By volume in 2022–2025: Education during COVID-19 pandemic, Monoclonal and Polyclonal Antibodies Research, SARS-CoV-2 and COVID-19 Research and Genomics, phytochemicals, and oxidative stress.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Education during COVID-19 pandemic Education 0 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 4 Genomics, phytochemicals, and oxidative stress Molecular Biology 0 works
- 5 Piperaceae Chemical and Biological Studies Pharmacology 0 works
- 6 vaccines and immunoinformatics approaches Molecular Biology 0 works
- 7 Vaccine Coverage and Hesitancy Health 0 works
- 8 Plant biochemistry and biosynthesis Molecular Biology 0 works
- 9 Biochemical and Structural Characterization Molecular Biology 0 works
- 10 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has National Institute of Science and Technology of Drugs and Medicines's research output changed?
Output in 2018–2022 was 29% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rio de Janeiro
- Universidade Federal do Rio de Janeiro
- Universidade do Estado do Rio de Janeiro
- Fundação Oswaldo Cruz
- Pontifícia Universidade Católica do Rio de Janeiro
- Universidade Federal do Estado do Rio de Janeiro
- Fundação Getulio Vargas
- Petrobras (Brazil)
- State University of Norte Fluminense
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.